Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00279279 · ClinicalTrials.gov registry record · NA

PREPARE - Primary Prevention Parameters Evaluation

A NA study, sponsored by Medtronic Cardiac Rhythm and Heart Failure.

Completed
Registry status
NA
Development phase
700
Enrollment target

NCT00279279: Completed NA study, sponsored by Medtronic Cardiac Rhythm and Heart Failure.

NCT00279279 is a NA study that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 700 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (50% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00279279, a NA study, has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.

COMPLETED
Registry status
NA
Development phase
700 participants
Enrollment target

Study Summary

The purpose of this study is to test specific device programming in patients without a previous history of a life-threatening, abnormally fast heartbeat who are implanted with a Medtronic ICD (Implantable Cardioconverter Defibrillator) or ICD with CRT (Cardiac Resynchronozation Therapy) device. The information learned from this study could be used to guide physicians in future ICD or CRT device programming.

Interventions

  • DEVICE Implanted Device

Trial Details

FieldValue
Enrollment Target 700 participants
Start Date 2003-10
Est. Completion 2006-05
Phase NA

What the finished NCT00279279 record still lists

NCT00279279 is an interventional study that assigns participants to a tested intervention. The registered 700 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (50% lower).

The record links to 0 conditions, and to 1 intervention - of which Implanted Device is the first listed.

NCT00279279 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00279279 about?

NCT00279279 is a clinical study titled "PREPARE - Primary Prevention Parameters Evaluation". The purpose of this study is to test specific device programming in patients without a previous history of a life-threatening, abnormally fast heartbeat who are implanted with a Medtronic ICD (Implantable Cardioconverter Defibrillator) or ICD with CRT (Cardiac Resynchronozation Therapy) device. The ...

What is the current status of trial NCT00279279?

This trial is currently completed. It is a NA study. The enrollment target is 700 participants. The study started on 2003-10. Estimated completion is 2006-05.

What interventions are being tested in trial NCT00279279?

The interventions under investigation include: Implanted Device (DEVICE).

Who is sponsoring clinical trial NCT00279279?

This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00279279's enrollment target sits among peer trials

700 149th of 2000 higher than 1,850 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00900419 · 700 participants

    Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers

  • NCT01804686 · 700 participants · Phase 3

    A Long-term Extension Study of PCI-32765 (Ibrutinib)

  • NCT02107989 · 700 participants

    Noninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy and Establishment of a Normative Imaging Database

  • NCT02129543 · 700 participants

    Immune Reconstitution in Stem Cell Transplant Recipients

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00279279, the US trial registry maintained by the National Library of Medicine. NCT00279279 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.